About Bova
Bova is a Healthcare company based in London (United Kingdom) founded in 2008, and was acquired by Vimian in March 2022. Manufacturer of veterinary medicines and supplements. The company has 29 employees. Bova offers products and services including Veterinary Pharmaceuticals, Webinars, and Podcasts. Its focus areas include HealthTech, Veterinary HealthTech, Biopharmaceuticals and Diversified. Its legal entity is BOVA SPECIALS UK LIMITED. Its competitors include PetMedix and The Vaccine Group; 2 of its 2 listed competitors have raised funding.
Company details
Bova was founded in 2008 and is headquartered in London, United Kingdom. Operations are centered on the veterinary sector, where sterile and non-sterile products are developed and produced. These include oral suspensions, transdermal creams, thermo-reversible gels, sterile injectables, ophthalmic preparations, cytotoxic agents, and capsules. The focus remains on supplying the veterinary market with specialized formulations.
- Headquarters London, United Kingdom
- Employees 29
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website bova.co.uk
- Social LinkedIn Facebook Instagram
- Acquired by Vimian (Mar 2022)
- Legal Name Bova Specials Uk Limited
- Date of Incorporation 21 Mar, 2016
- Jurisdiction LONDON, UNITED KINGDOM
Products & Services of Bova
Bova offers a comprehensive portfolio of products and services, including Veterinary Pharmaceuticals, Webinars, and Podcasts.
Innovative drugs for treating animal health conditions
Online sessions for veterinary professional development
Audio content on animal health topics for vets
Investors in Bova
Bova has secured backing from 1 investor. Prominent investors backing the company include Vimian.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Innovative technology solutions for animal health improvement are provided. | 2016 | vimian.com | Stockholm, Sweden |
Investor details for Bova
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Bova
1 people are tracked at Bova (1 in leadership); the tracked headcount is 29.
| Name | Role | Group |
|---|---|---|
Nick Bova | Managing Director | Leadership |
Complete people profiles for Bova
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Bova
2 dated milestones of Bova across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Bova is founded.
- Exit Acquired by Vimian.
Competitors of Bova
Bova has 2 listed competitors in our database, 2 of them funded. They include PetMedix and The Vaccine Group.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| petmedix.com | 2017 | Babraham, United Kingdom | $47.46M | 44 | Developer of monoclonal antibody therapeutics for pets | |
| thevaccinegroup.com | 2017 | Plymouth, United Kingdom | $753,991 | 11 | Herpesvirus-based animal vaccines are developed against infectious diseases. |
Detailed competitors of Bova
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Bova
The website of Bova (bova.co.uk) receives about 6.3K visits a month.
- Monthly visits6.3K
▲ 56.7% vs previous month
Websites whose visitors overlap most with Bova. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
svprx.co.uk | svprx.co.uk | 100% | #4,410,266 | – | |
| msd-uk.com | 87% | 7.2K | #2,764,472 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bova
Bova was founded in 2008.
Bova is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Bova has 29 employees.
Annual revenue of Bova is $17.03M as on Dec 31, 2023.
Bova was founded in 2008 and is headquartered in London, United Kingdom. Operations are centered on the veterinary sector, where sterile and non-sterile products are developed and produced. These include oral suspensions, transdermal creams, thermo-reversible gels, sterile injectables, ophthalmic preparations, cytotoxic agents, and capsules. The focus remains on supplying the veterinary market with specialized formulations.
Bova's top competitors include PetMedix and The Vaccine Group.
Bova offers Veterinary Pharmaceuticals, Webinars, and Podcasts.
Bova has 1 investor. Key investors include Vimian.
Bova operates through Bova Specials Uk Limited.
Yes. Bova was acquired by Vimian in March 2022.